01 Ischemic Heart Disease
Angina and MI are both downstream consequences of a ruptured or flow-limiting atherosclerotic plaque, whose formation is covered in Atherosclerosis, Dyslipidemia & Lipid Pharmacology → Atherogenesis.
Angina spectrum
| Type | Trigger | Mechanism | Necrosis? |
|---|---|---|---|
| Stable angina | Exertion, relieved by rest | Fixed atherosclerotic stenosis limiting supply under demand | No |
| Prinzmetal (variant) angina | Occurs at rest | Coronary artery vasospasm | No |
| Unstable angina | New, worsening, or rest pain | Ruptured plaque with partial (non-occlusive) thrombus | No |
The three angina types split cleanly by mechanism, not just symptom pattern: stable is a fixed supply-demand mismatch, Prinzmetal is a supply problem from vasospasm even at rest, and unstable is a partial thrombus superimposed on plaque — the last two both need urgent workup despite looking similar to the patient.
- Symptoms of angina typically appear once a coronary vessel is roughly 90% occluded; anginal pain classically lasts only a few minutes and produces transient ST-segment depression during the episode.
- Anti-anginal treatment for stable disease centers on nitrates, beta-blockers, and calcium channel blockers.
- Nitrates are converted to nitric oxide, causing venodilation that lowers preload (and modest coronary dilation); sublingual nitroglycerin is first-line for acute attacks, and longer-acting nitrates (e.g., isosorbide dinitrate) are used for prophylaxis; expect headache, tachyphylaxis, orthostatic hypotension, and flushing. Never combine nitrates with a PDE-5 inhibitor (e.g., sildenafil) — both raise cGMP through the same pathway, and the combination can cause severe, refractory hypotension; nitrates are also avoided in right ventricular infarction and hypertrophic cardiomyopathy, since both depend on adequate preload.
- Unstable angina is managed with anticoagulation (heparin, low-molecular-weight heparin, aspirin), nitrates, and beta-blockers; calcium channel blockers and thrombolytics are not appropriate for unstable angina.
- Cocaine can precipitate ischemia through coronary vasospasm by blocking reuptake of catecholamines (dopamine, norepinephrine, epinephrine, serotonin) at the synapse, in contrast to amphetamines, which stimulate catecholamine release.
- The LAD artery is the vessel most commonly occluded in MI.
Diagnostic testing for suspected chronic coronary disease
- Exercise (or pharmacologic) stress testing is a standard way to unmask subacute/chronic coronary occlusion that isn't apparent at rest.
- Thallium-201 perfusion scanning reveals regions of reduced perfusion (defects) during stress.
- Technetium-99m scanning is useful for imaging areas of prior infarction.
How antianginals reduce oxygen demand
Antianginal therapy works by lowering one or more of the determinants of myocardial oxygen consumption: end-diastolic volume, blood pressure, heart rate, and contractility.
| Determinant | Nitrates | Beta-blockers | Nitrates + beta-blocker |
|---|---|---|---|
| End-diastolic volume | ↓ | No change or ↑ | No change or ↓ |
| Blood pressure | ↓ | ↓ | ↓↓ |
| Contractility | ↑ (reflex) | ↓ | Little/no net change |
| Heart rate | ↑ (reflex) | ↓ | No change or ↓ |
| Net O₂ demand | ↓ | ↓ | ↓↓ |
- Because nitrates alone trigger reflex tachycardia and increased contractility, pairing them with a beta-blocker blunts that reflex and produces a larger net reduction in oxygen demand than either drug alone.
- Ranolazine is reserved for refractory angina: it inhibits the late inward sodium current, which indirectly reduces intracellular calcium overload and diastolic wall tension — without changing heart rate or blood pressure. Watch for constipation and QT prolongation.
Myocardial infarction
- Caused by a fixed occlusive thrombus over a ruptured plaque, cutting off perfusion to downstream myocardium.
- Subendocardial tissue is most vulnerable first, since it receives the least perfusion reserve during systole.
| NSTEMI | STEMI | |
|---|---|---|
| Extent of infarct | Partial (subendocardial) thickness | Full (transmural) thickness |
| ECG | ST depression; no Q waves | ST elevation; Q waves develop |
| Troponin | Elevated | Elevated |
ECG localization of STEMI
| Infarct territory | Culprit vessel | Leads with ST elevation |
|---|---|---|
| Anteroseptal | LAD | V1–V2 |
| Anteroapical | Distal LAD | V3–V4 |
| Anterolateral | LAD or LCX | V5–V6 |
| Lateral | LCX | I, aVL |
| Inferior | RCA (or LCX) | II, III, aVF |
| Posterior | Posterior descending artery | ST depression (not elevation) in V1–V3, with tall R waves — a mirror-image pattern; confirmed with posterior leads V7–V9 |
Standard 12-lead ECGs have no posterior leads, so a posterior MI shows up as the electrical "opposite" of what an anterior infarct would look like from that same territory — ST depression and tall R waves in V1–V3 instead of elevation and Q waves.
Time course of infarction
- Cardiac troponin rises within a few hours, peaks around 24 hours, and stays elevated for roughly a week or more — the most sensitive/specific marker and the earliest to rise.
- CK-MB rises and falls faster than troponin, making it useful for detecting reinfarction within days of an initial event.
- AST and LDH rise later and more slowly, following behind troponin and CK-MB — historically used but now largely superseded by troponin.
- Because it preferentially blocks partially depolarized (ischemic) tissue over normal tissue — a state-dependent effect — IV lidocaine is useful for suppressing acute MI-associated ventricular arrhythmias.
Troponin's long elevation window makes it useless for detecting reinfarction days later, since it's still up from the first event — that's specifically why CK-MB, which clears faster, remains relevant despite being less sensitive/specific overall.
Chronic ischemic patterns
- Myocardial hibernation: a chronically underperfused segment of viable myocardium downregulates its contractile function to match the reduced blood supply; this systolic dysfunction is potentially reversible with revascularization.
- Myocardial stunning: a brief episode of acute ischemia (e.g., after successful reperfusion) leaves transient, reversible contractile dysfunction even though blood flow has been restored.
- Coronary steal syndrome: distal to a fixed coronary stenosis, resistance vessels are already maximally dilated to compensate for reduced flow. Giving a vasodilator (dipyridamole, adenosine, regadenoson) dilates the healthy vessels further, dropping their resistance and diverting ("stealing") blood away from the already-maximally-dilated, stenosed territory — the basis of vasodilator stress testing, which detects this flow mismatch even though it can, rarely, provoke true ischemia.
Complications by timing
| Timing | Complication |
|---|---|
| Minutes–hours | Lethal arrhythmia (especially ventricular fibrillation) — the leading cause of early post-MI death |
| Days | Papillary muscle rupture → acute mitral regurgitation; free wall rupture → tamponade (risk peaks around day 4–8, when the necrotic wall is weakest and macrophage-mediated debris clearance is active); mural thrombus can form over the akinetic infarcted segment and embolize |
| Weeks | Dressler syndrome — autoimmune pericarditis with fever and pleuritic pain |
| Months | Ventricular aneurysm, progressive ischemic cardiomyopathy, chronic heart failure; scar remodeling continues for roughly 1–3 months after the infarct |
Post-MI management
- Revascularization (thrombolysis or percutaneous intervention) when timely.
- Antiplatelet therapy (aspirin), anticoagulation, nitrates, and analgesia acutely.
- Long-term secondary prevention: beta-blockers, ACE inhibitors, statins, and aspirin all reduce mortality/remodeling.
- Sudden cardiac death occurring within a short window of symptom onset is most often arrhythmic and typically occurs against a background of significant coronary atherosclerosis.
02 Congestive Heart Failure
Whether reduced-EF or preserved-EF failure develops depends on the same preload, afterload, and Frank–Starling relationships covered in Conduction System & Cardiac Physiology → Frank–Starling (contractility) curves.
Left- vs. right-sided failure
| Left-sided | Right-sided | |
|---|---|---|
| Common causes | Ischemic heart disease, hypertension, left-sided valve disease | Most often secondary to left-sided failure; also cor pulmonale, right-sided valve disease |
| Findings | Pulmonary congestion, dyspnea/orthopnea, paroxysmal nocturnal dyspnea, S3 | Hepatomegaly ("nutmeg liver"), ascites, peripheral/dependent edema, jugular venous distension |
The left/right split simply reflects which circulation backs up behind the failing chamber — left failure floods the lungs, right failure floods the systemic venous system — and since right-sided failure is most often caused by left-sided failure, biventricular findings are common by the time a patient presents.
Systolic vs. diastolic (HFrEF vs. HFpEF)
- HFrEF (reduced ejection fraction, systolic dysfunction): the ventricle can't contract normally, so ejection fraction falls and end-diastolic volume rises; classic causes are prior MI or dilated cardiomyopathy.
- HFpEF (preserved ejection fraction, diastolic dysfunction): ejection fraction stays roughly normal, but a stiff, poorly compliant ventricle (often from chronic hypertension-driven hypertrophy) can't fill properly, so filling pressures rise for a given volume.
- B-type natriuretic peptide (BNP), released by stretched ventricular myocytes in response to wall tension, is a useful blood test for diagnosing heart failure — a very good negative predictive value makes a low BNP helpful for ruling HF out.
Pathophysiologic loop
- This compensatory neurohormonal activation initially supports blood pressure but ultimately worsens congestion and remodeling — the rationale for RAA-axis blockade in treatment.
- ACE inhibitors and beta-blockers reduce mortality in chronic systolic heart failure; digoxin improves symptoms but not mortality.
Pharmacologic management
| Class | Effect on CHF | Mortality benefit? |
|---|---|---|
| ACE inhibitors / ARBs | ↓ afterload, blunt aldosterone-driven fluid retention | Yes — first-line |
| Beta-blockers | Blunt chronic sympathetic overdrive, improve remodeling | Yes, in stable chronic systolic failure |
| Diuretics | Relieve congestive symptoms | Symptomatic only |
| Digoxin | ↑ contractility via Na⁺/K⁺-ATPase inhibition | Symptomatic only, narrow therapeutic index |
| Aldosterone antagonists (spironolactone, eplerenone) | Block aldosterone-driven fibrosis and fluid retention | Yes, in HFrEF |
| Angiotensin receptor–neprilysin inhibitor (sacubitril/valsartan) | Neprilysin inhibition raises natriuretic peptide, bradykinin, and angiotensin II levels; the paired ARB blocks the unwanted angiotensin II effect, leaving net vasodilation and natriuresis | Yes, superior to ACE inhibitor alone in HFrEF; never combine with an ACE inhibitor (risk of angioedema from excess bradykinin) |
| SGLT2 inhibitors | Promote natriuresis/glucosuria and favorably alter cardiac metabolism | Yes, in HFrEF (mortality and symptom benefit, independent of diabetes status) |
| Hydralazine + nitrate | Arterial + venous vasodilation, reducing both afterload and preload | Yes, particularly benefits Black patients with HFrEF |
| Ivabradine | Selectively inhibits the "funny" sodium current (If) in the SA node, slowing heart rate without affecting contractility or blood pressure | Adjunct in chronic HFrEF with a persistently elevated heart rate despite beta-blockade; can cause visual brightness/phosphenes |
The mortality-benefit column tracks which drugs blunt chronic neurohormonal overactivation (RAAS, sympathetic drive) rather than which drugs simply make the heart pump harder — this is why digoxin and diuretics help symptoms without extending survival, while ACE inhibitors and beta-blockers do both.
- Digoxin's inotropic mechanism cascade: blocking the Na⁺/K⁺-ATPase raises intracellular sodium, which reduces the activity of the Na⁺/Ca²⁺ antiporter, which in turn raises intracellular calcium available for contraction.
- ACE inhibitor adverse effects include reversible renal insufficiency, hyperkalemia, angioedema, dry cough (bradykinin-mediated), and orthostatic hypotension; they are fetotoxic and contraindicated in pregnancy.
- Cor pulmonale is right-sided heart failure caused by a primary lung disorder that produces pulmonary arterial hypertension.
- High-output heart failure is an uncommon pattern where cardiac output is actually elevated but still can't meet the body's needs, because systemic vascular resistance has fallen sharply (severe anemia, hyperthyroidism, arteriovenous shunting/fistula, wet beriberi, advanced cirrhosis, severe obesity, or Paget disease of bone). It still presents with the same signs of venous congestion as low-output failure.
- Milrinone is a short-term IV inotrope/vasodilator for acute decompensated heart failure or cardiogenic shock: by inhibiting phosphodiesterase-3, it raises intracellular cAMP in the myocardium (↑ contractility) and in vascular smooth muscle (vasodilation). It is not used chronically, since long-term phosphodiesterase-3 inhibition increases mortality.
03 Arrhythmias & Antiarrhythmic Pharmacology
Heart blocks and the Vaughan Williams drug classes both act on the pacemaker and myocardial action potential phases described in Conduction System & Cardiac Physiology → Pacemaker vs. myocardial action potentials.
Normal ECG landmarks
- P wave: atrial depolarization.
- PR interval (0.12–0.20 s): atrial-to-ventricular conduction time, mostly reflecting AV nodal delay.
- QRS (< 0.10 s normally): ventricular depolarization.
- T wave: ventricular repolarization; inversion can indicate ischemia or a recent MI.
- U wave: a small deflection after the T wave, most notably prominent in hypokalemia (also seen with bradycardia).
Heart blocks
| Block | ECG pattern | Significance |
|---|---|---|
| First-degree | Fixed, prolonged PR (>0.20 s) | Usually benign, often drug-related |
| Second-degree, Mobitz I (Wenckebach) | Progressively lengthening PR until a beat is dropped | Usually benign, rarely needs treatment |
| Second-degree, Mobitz II | Fixed PR with intermittently dropped QRS | Infra-nodal disease; can progress suddenly to complete block — often needs a pacemaker |
| Third-degree (complete) | No relationship between P waves and QRS complexes | Atria and ventricles beat independently; usually needs a pacemaker |
What actually determines prognosis is the anatomic level of block, not the ECG pattern itself: Mobitz I is AV nodal (usually benign, vagally mediated) while Mobitz II is infra-nodal, in the His-Purkinje system, where escape rhythms are unreliable — that's the real reason Mobitz II gets a pacemaker and Mobitz I usually doesn't.
Tachyarrhythmia patterns
- Atrial fibrillation: chaotic, disorganized atrial activity with an irregularly irregular ventricular response; risk of atrial mural thrombus and embolic stroke.
- Atrial flutter: organized "sawtooth" atrial activity around 300/min with a regular conduction ratio (e.g., 2:1).
- Ventricular tachycardia: wide, regularly-shaped QRS complexes at a rapid rate; AV dissociation may be present.
- Ventricular fibrillation: chaotic, disorganized ventricular activity — a pulseless, life-threatening rhythm.
- Torsades de pointes: polymorphic VT with QRS amplitude that appears to twist around the baseline; associated with QT prolongation.
- Wolff–Parkinson–White: an accessory bypass tract preexcites the ventricle, producing a short PR interval and a slurred initial QRS upstroke (delta wave).
Premature beats
- Premature atrial contraction: an early beat from an ectopic atrial focus rather than the SA node; narrow QRS with a preceding (often abnormal-looking) P wave. Usually benign and often triggered by caffeine or adrenergic drive, though frequent PACs raise the risk of atrial fibrillation/flutter.
- Premature ventricular contraction: an early, wide QRS beat with no preceding P wave, arising from a ventricular focus; shortens diastolic filling time and so lowers that beat's stroke volume. Prognosis depends mainly on the underlying heart disease.
Sick sinus syndrome and hereditary channelopathies
- Sick sinus syndrome: age-related degeneration of the SA node producing bradycardia, sinus pauses, sinus arrest, or alternating brady-tachycardia; may need a pacemaker if symptomatic.
- Brugada syndrome: autosomal dominant, usually from a loss-of-function sodium channel mutation, more prevalent in males of Asian descent; ECG shows a pseudo-right-bundle-branch-block pattern with ST elevation in the right precordial leads (V1–V3) and confers a real risk of sudden cardiac death — managed with an implantable defibrillator.
- Congenital long QT syndrome: usually a loss-of-function potassium channel mutation impairing repolarization, predisposing to torsades de pointes. Romano-Ward syndrome is autosomal dominant with a purely cardiac phenotype; Jervell and Lange-Nielsen syndrome is autosomal recessive and adds sensorineural deafness.
Antiarrhythmic drug classes (Vaughan Williams)
| Class | Target | Agents | Key notes |
|---|---|---|---|
| IA | Na⁺ channel (moderate block, slows phase 0); also prolongs phase 3 repolarization | Quinidine, procainamide, disopyramide | Widens QRS and prolongs QT; risk of torsades |
| IB | Na⁺ channel; shortens phase 3 | Lidocaine, mexiletine | Preferentially affects ischemic/depolarized tissue; useful post-MI ventricular arrhythmias; lidocaine also serves as a local anesthetic |
| IC | Na⁺ channel — markedly slows phase 0; minimal effect on repolarization | Flecainide, propafenone | Avoid after MI/structural heart disease — proarrhythmic; reserved for refractory ventricular or supraventricular arrhythmias in structurally normal hearts |
| II | β-adrenergic receptor; suppresses phase 4 depolarization rate | Metoprolol, esmolol, propranolol | Slow SA/AV nodal rate; reduce mortality post-MI |
| III | K⁺ channel; prolongs phase 3 | Amiodarone, sotalol | Prolongs QT; used for Wolff–Parkinson–White or when other agents fail; amiodarone has additional class I/II/IV actions and unique organ toxicities |
| IV | Ca²⁺ channel (cardiac/nodal); slows the action potential | Verapamil, diltiazem | Slow AV nodal conduction; useful for supraventricular arrhythmias |
Only classes II and III carry a proven mortality benefit; classes IA, IC, and (to a lesser extent) IV are themselves proarrhythmic — so "which class treats X arrhythmia" and "which class is safe to use long-term" are separate questions the exam likes to conflate.
- Digoxin's therapeutic ECG signature is distinct from toxicity: it increases the PR interval, decreases the QT interval, depresses the ST segment, and inverts the T wave.
Other antiarrhythmic agents
- Adenosine: transiently blocks AV nodal conduction by increasing potassium efflux and hyperpolarizing nodal tissue, effectively terminating reentry circuits that depend on the AV node; very short half-life (seconds); first-line for terminating reentrant supraventricular tachycardia and useful diagnostically to unmask atrial activity or distinguish a supraventricular from a ventricular origin of a wide-complex tachycardia. Side effects include flushing, transient hypotension, and chest pain.
- Digoxin: inhibits the myocyte Na⁺/K⁺-ATPase, indirectly raising intracellular calcium via the Na⁺/Ca²⁺ exchanger; increases contractility and slows AV conduction.
- Potassium: useful in digoxin toxicity with hypokalemia, since low potassium potentiates digoxin binding.
Rhythm-specific treatment approach
| Rhythm | First-line approach |
|---|---|
| Atrial fibrillation | Rate control (beta-blocker, diltiazem, verapamil, or digoxin) is generally preferred over rhythm control; if rhythm control is pursued, electrical cardioversion or an antiarrhythmic (commonly amiodarone) may restore sinus rhythm, though reversion to fibrillation is common |
| Supraventricular tachycardia | Adenosine for acute termination/diagnosis; verapamil for longer-term control |
| Ventricular fibrillation | Lidocaine or amiodarone |
| Torsades de pointes | IV magnesium |
Rate control being preferred over rhythm control for atrial fibrillation reflects trial evidence that the two strategies produce similar mortality — so the harder question isn't which rhythm is "better," it's whether the patient still needs anticoagulation regardless of which strategy is chosen (they usually do).
- Chronic atrial fibrillation predisposes to atrial thrombus with systemic embolization, so anticoagulation (e.g., warfarin) is used to prevent stroke.
- Diltiazem is particularly useful for controlling ventricular rate in atrial fibrillation because it slows AV nodal conduction.
- Every antiarrhythmic drug can itself provoke new arrhythmias, particularly when started or stopped abruptly.
- An MI can itself cause second- or third-degree heart block by damaging the conduction system.
Digoxin toxicity
- Presents with GI symptoms, visual disturbances (yellow-green halos), confusion, and dangerous arrhythmias.
- Toxicity risk rises with renal impairment (reduced clearance), hypokalemia (potentiates binding), and quinidine (displaces digoxin from tissue binding sites and reduces its clearance).
- Management: repeated-dose activated charcoal; avoid giving calcium in associated hyperkalemia, since it can worsen intracellular calcium overload; give atropine if bradycardia is present; treat hyperkalemia only if it is producing ECG changes.
- Digoxin-specific antibody fragments (Fab) are reserved for severe toxicity — hemodynamic instability, life-threatening arrhythmia or severe bradycardia unresponsive to atropine, markedly elevated potassium or digoxin level, a large ingested dose, or a digoxin-toxic rhythm with an elevated level.
Adverse effects by antiarrhythmic class
- Class IA: quinidine causes cinchonism (headache, tinnitus, thrombocytopenia); procainamide can cause a reversible lupus-like syndrome; both risk torsades de pointes.
- Class IB: CNS stimulation/depression is common to the group; long-term tocainide use can also cause neutropenia and thrombocytopenia.
- Class IC: proarrhythmic, especially post-MI — avoided in structural/ischemic heart disease.
- Class II (beta-blockers): bradycardia, AV block, bronchospasm, heart failure exacerbation, sedation, sleep disturbance; class II and class III agents are the antiarrhythmic groups shown to reduce mortality, whereas most other antiarrhythmics can themselves be proarrhythmic.
- Class III: amiodarone carries broad, distinctive toxicity beyond its class III action — pulmonary fibrosis, corneal deposits, hepatotoxicity, skin discoloration/photodermatitis, thyroid dysfunction (more often hypothyroidism), and neurologic effects, in addition to bradycardia/heart block.
- Class IV (non-dihydropyridine CCBs): constipation, flushing, peripheral edema, AV block, sinus node depression.
Beyond the antiarrhythmics themselves, a wide range of other drug classes can prolong the QT interval and predispose to torsades de pointes — remembered with "ABCDEF+NO": Antiarrhythmics (class IA/III), Arsenic, Biotics (macrolides, fluoroquinolones), Cychotics (haloperidol), Chloroquine, Depressants (TCAs), Diuretics (thiazides), Emetics (ondansetron), Fungals (fluconazole), protease iNhibitors, Opioids (methadone).
04 Hypertension & Antihypertensive Pharmacology
ACE inhibitors, ARBs, and the volume/pressure effects of secondary hypertension all hinge on the renin-angiotensin-aldosterone cascade detailed in Conduction System & Cardiac Physiology → Neurohormonal regulation.
Classification
- Essential (primary) hypertension: accounts for roughly 95% of cases; multifactorial, no single identifiable cause; diagnosed after blood pressure is found above 140/90 mm Hg on three separate occasions with the patient seated comfortably.
- Secondary hypertension: attributable to an identifiable condition.
Renal causes of secondary HTN
- Chronic kidney disease (most common overall)
- Renal artery stenosis — atherosclerotic (more common in older Black men) or fibromuscular dysplasia (more common in younger White women, producing a classic "beads-on-a-string" appearance on renal angiography)
Endocrine / other causes
- Primary aldosteronism, pheochromocytoma, Cushing syndrome
- Hyperthyroidism, acromegaly
- Coarctation of the aorta
Hypertensive urgency vs. emergency
- Both involve severely elevated blood pressure (roughly ≥180/120 mm Hg).
- Urgency: no acute end-organ damage.
- Emergency: evidence of acute end-organ damage — encephalopathy, aortic dissection, pulmonary edema, acute kidney injury, papilledema.
- Emergencies require controlled IV blood-pressure reduction (e.g., nitroprusside, labetalol, nicardipine, clevidipine, or fenoldopam) rather than pure beta-blockade, since unopposed alpha stimulation can worsen vasoconstriction.
- Malignant (emergency) hypertension is a major cause of early death via cerebrovascular accident and has classically been described as disproportionately affecting young Black men.
Chronic end-organ effects of hypertension
- Left ventricular hypertrophy (also seen with aortic stenosis and mitral regurgitation).
- Arteriolosclerosis ("hyaline" or "hyperplastic onion-skinning" of small vessel walls).
- Retinal hemorrhages/exudates.
Antihypertensive drug classes
| Class | Mechanism | Notable use / caution |
|---|---|---|
| Thiazide diuretics | Inhibit Na⁺/Cl⁻ cotransport in the distal convoluted tubule | First-line for many; also used for idiopathic hypercalciuria and nephrogenic diabetes insipidus; can cause hypokalemia, hypercalcemia, hyperglycemia, hyperuricemia; avoid with sulfa allergy |
| Loop diuretics | Inhibit Na⁺/K⁺/2Cl⁻ cotransport in the thick ascending limb | Preferred when volume overload dominates; also used to treat hypercalcemia (calciuretic); potassium wasting, ototoxicity; avoid with sulfa allergy |
| ACE inhibitors | Block conversion of angiotensin I to II | Renoprotective in diabetes; cough and angioedema (bradykinin-mediated); use caution in bilateral renal artery stenosis (can precipitate renal failure); avoid in pregnancy |
| ARBs | Block the angiotensin II receptor | Same benefits as ACE inhibitors without the cough; still carry hyperkalemia risk and fetal renal toxicity |
| Beta-blockers — nonselective (β1+β2) | Block both receptor subtypes | Propranolol, timolol, nadolol |
| Beta-blockers — β1-selective (cardioselective) | Preferentially block β1 | Metoprolol, atenolol, acebutolol, esmolol (esmolol is very short-acting); class-wide adverse effects also include male sexual dysfunction and rebound arrhythmia if stopped abruptly |
| Combined α/β-blockers | Block α1 and β receptors | Carvedilol, labetalol — useful when both vasodilation and rate control are wanted (e.g., hypertensive emergency, aortic dissection) |
| Guanethidine | Interferes with norepinephrine release from sympathetic terminals | Reserved for severe hypertension; contraindicated with tricyclic antidepressants |
| Reserpine | Depletes monoamine stores from synaptic vesicles | Adverse effects include depression and sedation |
| Hexamethonium | Nicotinic ganglionic blocker | Historic agent for hypertensive emergency; severe orthostatic hypotension |
| Diazoxide | Potassium-channel opener; hyperpolarizes and relaxes vascular smooth muscle | Can cause hypoglycemia by reducing insulin release |
| Dihydropyridine CCBs | Block vascular smooth-muscle Ca²⁺ channels | Also used for Prinzmetal angina and Raynaud phenomenon; peripheral edema, flushing, reflex tachycardia |
| Non-dihydropyridine CCBs | Block cardiac Ca²⁺ channels | Negative inotropy/chronotropy; avoid combining with beta-blockers |
| α1-blockers | Block vascular α1 receptors → vasodilation | Also treats benign prostatic hyperplasia; first-dose orthostatic hypotension |
| Central α2-agonists (clonidine, methyldopa) | Reduce sympathetic outflow from the CNS | Clonidine also used for opioid/cocaine withdrawal symptoms; dry mouth and rebound hypertension if stopped abruptly. Methyldopa preferred in pregnancy; can cause a positive Coombs test and hemolytic anemia |
| Direct vasodilators (hydralazine, minoxidil) | Relax arteriolar smooth muscle | Reflex tachycardia and fluid retention; hydralazine can cause a lupus-like reaction and is avoided in angina/CAD (reflex tachycardia); used with methyldopa in pregnancy. Minoxidil can cause hypertrichosis and pericardial effusion |
| Nitroprusside | Releases nitric oxide → arterial and venous dilation | Hypertensive emergencies; risk of cyanide toxicity with prolonged use |
| Fenoldopam | Selective dopamine D1 receptor agonist → coronary, peripheral, renal, and splanchnic vasodilation | Hypertensive emergency, including in renal impairment (also promotes natriuresis); can cause reflex tachycardia and flushing |
Beta-blocker effects by organ system
| System | Effect | Clinical relevance |
|---|---|---|
| Cardiac (β1) | ↓ contractility, ↓ heart rate, slowed SA/AV conduction | Useful in angina, arrhythmia, post-MI prophylaxis; bradycardia can limit dosing |
| Pulmonary (β2) | Bronchial smooth muscle constriction | Relatively contraindicated in reactive airway disease/COPD |
| Endocrine | ↓ glycogenolysis, ↓ glucagon release | Masks adrenergic hypoglycemia symptoms (tremor, palpitations) — risky in insulin-treated diabetics |
| Ocular | ↓ aqueous humor production by the ciliary body | Topical timolol is used to treat glaucoma |
This whole table is just one receptor blockade playing out in different tissues — the "side effects" (bronchospasm, masked hypoglycemia, sedation-adjacent CNS effects) and the "therapeutic uses" (angina, glaucoma) are the same β-blockade mechanism, just applied to different organs.
- Beyond hypertension, beta-blockers are used for stable angina, post-MI prophylaxis, symptomatic control of hyperthyroidism, migraine prophylaxis, and anxiety disorder.
- Nonselective alpha-blockers (phenoxybenzamine, phentolamine) are used specifically to manage pheochromocytoma before and during surgery.
- Beta-blockers blunt the adrenergic warning signs of hypoglycemia (tremor, palpitations), which is especially risky for insulin-treated diabetics.
Choosing an antihypertensive by comorbidity
| Comorbidity | Favored agents | Why / what to avoid |
|---|---|---|
| Heart failure | ACE inhibitor/ARB, beta-blocker (once compensated), aldosterone antagonist, diuretic | Beta-blockers help mortality but must be introduced cautiously — avoid in acute decompensated HF and cardiogenic shock |
| Diabetes mellitus | ACE inhibitor/ARB, CCB, thiazide, beta-blocker | ACE inhibitors/ARBs are renoprotective; beta-blockers can mask hypoglycemia symptoms |
| Asthma/COPD | ARB, CCB, thiazide, cardioselective beta-blocker | Avoid non-selective beta-blockers (β2-mediated bronchoconstriction); avoid ACE inhibitors, since drug-induced cough can be confused with asthma symptoms |
| Pregnancy | Hydralazine, methyldopa, labetalol, nifedipine | ACE inhibitors/ARBs are contraindicated (fetal renal toxicity) |
| Gout | ACE inhibitor, CCB, ARB (especially losartan, which is mildly uricosuric) | Avoid loop and thiazide diuretics — they can precipitate gout flares |
| Osteoporosis | Thiazide (increases renal calcium reabsorption) | Combine with ACE inhibitor/ARB if additional control is needed |
| Pheochromocytoma | Alpha-blockade (phenoxybenzamine/phentolamine) first, then beta-blockade | Starting a beta-blocker first leaves alpha stimulation unopposed and can precipitate a hypertensive crisis |
Most of this table isn't about which drug lowers blood pressure most effectively — it's about which drug's off-target effect helps or actively harms a specific comorbidity, which is why the "favored" and "avoid" columns often point to drugs from the same class used elsewhere in this section.
05 Atherosclerosis, Dyslipidemia & Lipid Pharmacology
Atherogenesis
- The lipid-rich necrotic core is the most cholesterol-dense part of an established plaque.
- Plaque rupture exposes thrombogenic material, triggering platelet aggregation and acute thrombosis.
- Complications: occlusive thrombosis (MI, stroke), aneurysmal weakening of the wall, embolization of plaque debris, renal arterial ischemia, and death.
Plaque danger tracks vulnerability, not size: a thin fibrous cap over a large lipid-rich core is prone to rupture and acute thrombosis, whereas a heavily calcified, thick-capped plaque of similar or greater size can be more mechanically stable — which is why "stenosis severity" alone doesn't predict who has an MI.
- Fibrous atherosclerotic plaques occur with the greatest frequency in the abdominal aorta, followed by the proximal coronary arteries, the popliteal artery, the descending thoracic aorta, the internal carotid arteries, and finally the circle of Willis vessels.
Risk factors
Major / modifiable
- Dyslipidemia (high LDL, low HDL)
- Hypertension
- Cigarette smoking
- Diabetes mellitus
- Obesity
Minor / less modifiable
- Older age, male sex
- Family history
- Sedentary lifestyle
- Elevated homocysteine
- Estrogen loss (menopause), oral contraceptive use
Familial dyslipidemia patterns
- Type IIb (combined hyperlipidemia) and type IV (hypertriglyceridemia) are the two most common familial dyslipidemia patterns overall.
| Disorder | Elevated particle | Defect | Clinical clue |
|---|---|---|---|
| Familial hypercholesterolemia | LDL | Defective/absent LDL receptor | Tendon xanthomas, very early atherosclerosis |
| Dysbetalipoproteinemia | VLDL/chylomicron remnants | Abnormal apolipoprotein E | Tubero-eruptive and palmar xanthomas |
| Familial hypertriglyceridemia | VLDL | Hepatic VLDL overproduction | Common in obesity, diabetes, alcohol use, pregnancy |
Lipid-lowering agents
| Class | Mechanism | Effect | Key adverse effect |
|---|---|---|---|
| Statins | Inhibit HMG-CoA reductase, the rate-limiting step of hepatic cholesterol synthesis | ↓↓ LDL, mild ↑ HDL, mild ↓ TG | Myopathy, transaminase elevation |
| Niacin | Inhibits lipolysis in adipose tissue, reduces hepatic VLDL output | ↓ LDL, ↑↑ HDL, ↓ TG | Flushing (prostaglandin-mediated, reduced by aspirin pretreatment) |
| Bile acid resins | Bind intestinal bile acids, interrupting enterohepatic recirculation of cholesterol | ↓ LDL | GI upset, impaired fat-soluble vitamin absorption |
| Ezetimibe | Blocks intestinal cholesterol absorption at the brush border | ↓ LDL only | Generally well tolerated |
| Fibrates | Activate PPAR-α, upregulating lipoprotein lipase | ↓↓ TG, modest LDL/HDL change | Myopathy (especially with statins), cholesterol gallstones |
| PCSK9 inhibitors (alirocumab, evolocumab) | Block PCSK9-mediated degradation of the LDL receptor, so more receptors stay on the hepatocyte surface to clear LDL | ↓↓↓ LDL, mild ↑ HDL | Well tolerated; minimal drug interactions since they aren't CYP-metabolized |
| Fish oil / marine omega-3 fatty acids | Reduces hepatic VLDL production | ↓ TG at high doses, mild changes in LDL/HDL | Nausea, fishy aftertaste |
Statins are the only class here with robust outcome data showing reduced cardiovascular mortality independent of the LDL number itself (partly pleiotropic plaque-stabilizing effects) — so "biggest LDL drop" and "best survival benefit" aren't automatically the same drug.
Physical signs of hyperlipidemia
- Xanthomas: lipid-laden plaques or nodules in the skin, especially around the eyelids (xanthelasma).
- Tendinous xanthoma: lipid deposits in tendons, classically the Achilles tendon — a clue for familial hypercholesterolemia.
- Corneal arcus: a lipid ring at the edge of the cornea; common and benign in older adults (arcus senilis), but suggests hypercholesterolemia when it appears at a younger age.
06 Valvular Heart Disease
Mitral stenosis is usually a late sequela of rheumatic valve damage, whose autoimmune mechanism is covered in Myocarditis, Endocarditis & Rheumatic Heart Disease → Rheumatic heart disease.
Systolic murmurs
| Lesion | Murmur character | Notes |
|---|---|---|
| Aortic stenosis | Crescendo-decrescendo systolic ejection murmur, radiates to carotids | Degenerative calcification or bicuspid valve; syncope, angina, and heart failure are late warning symptoms |
| Mitral regurgitation | Holosystolic murmur radiating to the axilla | Louder with squatting/handgrip (↑ afterload) |
| Mitral valve prolapse | Midsystolic click ± late systolic murmur | Myxomatous leaflet degeneration; the most frequently occurring valvular lesion, often in young women and in Marfan syndrome; can cause chest pain, palpitations, or panic-attack-like symptoms |
| Ventricular septal defect | Harsh holosystolic murmur | Congenital |
- Aortic stenosis classically presents with syncope, angina, and heart failure — late and ominous signs.
Diastolic murmurs
| Lesion | Murmur character | Notes |
|---|---|---|
| Aortic regurgitation | Blowing, decrescendo diastolic murmur | Wide pulse pressure, water-hammer pulse |
| Mitral stenosis | Low-pitched diastolic rumble following an opening snap | Usually rheumatic in origin; left atrial enlargement |
- Maneuvers that increase venous return/preload (squatting, leg raise) or afterload (handgrip) tend to intensify regurgitant and stenotic left-heart murmurs, while maneuvers that reduce preload (standing, Valsalva strain) intensify the hypertrophic cardiomyopathy murmur and mitral valve prolapse click.
Maneuver effects, in more detail
| Maneuver | Hemodynamic change | Murmurs that get louder | Murmurs that get softer |
|---|---|---|---|
| Standing / Valsalva (strain phase) | ↓ preload → ↓ LV volume | Mitral valve prolapse click moves earlier; HCM murmur | Most other murmurs (less flow across the valve) |
| Squatting / passive leg raise | ↑ preload (and, with squatting, ↑ afterload) → ↑ LV volume | Most other murmurs (more flow across the valve) | Mitral valve prolapse click moves later; HCM murmur |
| Hand grip | ↑↑ afterload | Regurgitant left-sided murmurs (AR, MR), VSD | Aortic stenosis (smaller pressure gradient across the valve); HCM |
| Inspiration | ↑ venous return to the right heart, ↓ to the left heart | Right-sided murmurs | Left-sided murmurs (louder on expiration instead) |
Most murmurs get louder with more flow across the valve, so more preload/afterload = louder — HCM and MVP are the classic exceptions, where a smaller ventricular cavity brings the obstructing structures closer together, so less preload makes them louder instead.
Pressure–volume loop changes by lesion
| Lesion | EDV | ESV | Stroke volume | Loop shape |
|---|---|---|---|---|
| Aortic stenosis | Unchanged (if mild) | ↑ | ↓ | LV pressure must exceed a very high aortic pressure before ejection begins |
| Aortic regurgitation | ↑ | Variable | ↑ (but much of it regurgitates back) | No true isovolumetric phases — blood leaks across the incompetent valve even when it's nominally "closed" |
| Mitral stenosis | ↓ | ↓ | ↓ | Impaired filling limits how much volume the ventricle ever reaches |
| Mitral regurgitation | ↑ | ↓ | ↑ (total forward + backward flow) | No true isovolumetric phases — some blood regurgitates into the left atrium as soon as the ventricle starts contracting |
The loop shape sorts these lesions into two families: stenotic lesions are pressure-overload problems that preserve the normal isovolumetric phases, while regurgitant lesions are volume-overload problems that erase them, since the valve never truly seals.
07 Cardiomyopathies
Restrictive cardiomyopathy must be distinguished from constrictive pericarditis, whose hallmark prominent y descent is explained in Cardiac Tumors & Pericardial Disease → Jugular venous waveform abnormalities.
| Type | Core defect | Common causes | Clinical clues |
|---|---|---|---|
| Dilated | Systolic (contractile) dysfunction with chamber dilation | Idiopathic, alcohol, viral myocarditis, peripartum, thiamine deficiency, certain chemotherapy agents | Most common type; reduced ejection fraction, S3, cardiomegaly |
| Hypertrophic | Diastolic dysfunction from a stiff, thickened, poorly compliant ventricle | Usually autosomal dominant sarcomeric gene mutations | Young athletes, S4, murmur worsened by decreased preload (Valsalva) and improved by squatting; risk of sudden death |
| Restrictive | Diastolic dysfunction from a stiff, infiltrated ventricle wall | Amyloidosis, sarcoidosis, hemochromatosis | Preserved ejection fraction with poor filling; must be distinguished from constrictive pericarditis |
Hypertrophic and restrictive cardiomyopathy are both diastolic-dysfunction diseases with preserved-ish systolic function, but the underlying problem differs — HCM is an intrinsic sarcomeric/muscle disease making the wall thick and hypercontractile, while restrictive disease is infiltrative, stiffening the wall without necessarily thickening it.
- Stasis in a dilated, poorly contracting ventricle (or in a prolapsing mitral valve, or on fragmented endocarditis vegetations) predisposes to mural/valvular thrombus formation and systemic embolization.
- Amyloid-related restrictive cardiomyopathy has two main patterns: senile (age-related) amyloidosis derives from transthyretin, while primary (AL) amyloidosis derives from immunoglobulin light chains and is seen in plasma cell disorders.
- Idiopathic dilated cardiomyopathy is the most common form of cardiomyopathy overall; management includes digitalis, ACE inhibitors, heart transplantation, and sometimes chronic anticoagulation given the embolic risk.
Hypertrophic obstructive cardiomyopathy (HOCM)
- The subset of hypertrophic cardiomyopathy where asymmetric septal hypertrophy plus systolic anterior motion of the mitral valve obstructs the left ventricular outflow tract during systole — producing dyspnea and, in severe cases, exertional syncope.
- Because outflow obstruction worsens with a smaller, more vigorously contracting ventricle, drugs that reduce preload (diuretics, vasodilators) make symptoms worse and are avoided; high-intensity athletic activity is also avoided given the sudden-death risk.
- First-line treatment is a beta-blocker or a non-dihydropyridine CCB; the myosin inhibitor mavacamten is used for refractory symptoms, and an implantable defibrillator is added for patients at high risk of sudden death.
Stress (takotsubo) cardiomyopathy
- Transient apical ballooning of the left ventricle, likely from a surge of catecholamines during acute emotional or physical stress ("broken heart syndrome").
- Mimics an acute coronary syndrome clinically but occurs without obstructive coronary disease; usually reversible with supportive care.
- A memorable list of restrictive/infiltrative causes: Postradiation fibrosis, Löffler endocarditis (associated with hypereosinophilic syndrome), Endocardial fibroelastosis (a thick fibroelastic endocardium seen in young children), Amyloidosis, Sarcoidosis, Hemochromatosis.
08 Myocarditis, Endocarditis & Rheumatic Heart Disease
Untreated viral myocarditis can progress to chronic contractile failure, the dilated cardiomyopathy pattern covered in Cardiomyopathies.
Myocarditis
- Inflammation of the myocardium, most often viral — coxsackievirus B is the classic and most common cause of neonatal myocarditis; parvovirus B19 and human herpesvirus 6 are other common viral causes.
- HIV can cause myocarditis indirectly through opportunistic toxoplasmosis or cardiac involvement by Kaposi sarcoma.
- Bacterial causes include Staphylococcus aureus, Corynebacterium diphtheriae, and tuberculosis.
- Other causes: Chagas disease (Trypanosoma cruzi, transmitted by the reduviid/"kissing" bug), Lyme disease (Borrelia burgdorferi, transmitted by the Ixodes tick — stage 1 causes erythema chronicum migrans, stage 2 brings cardiac and neurologic involvement, stage 3 brings arthritis), hypersensitivity reactions, sarcoidosis.
- Findings: muffled S1, S3 gallop, mitral regurgitation murmur, cardiomegaly; can progress to dilated cardiomyopathy and arrhythmia.
Infective endocarditis
- Vegetations of organisms, platelets, and fibrin form on heart valves, most often on the mitral or aortic valve (tricuspid involvement suggests IV drug use).
- Classic peripheral findings: Janeway lesions (painless erythematous macules), Osler nodes (painful, tender nodules), splinter hemorrhages, Roth spots, and conjunctival petechiae — reflecting immune complex deposition and septic emboli.
| Subtype | Typical organism | Course |
|---|---|---|
| Acute | Staphylococcus aureus | Rapid onset, destructive, on previously normal valves |
| Subacute | Viridans streptococci | Indolent, over weeks to months, usually on previously damaged valves |
| Nonbacterial (marantic) | Sterile — associated with malignancy/hypercoagulable states | Sterile fibrin vegetations, embolic risk |
| Libman-Sacks | Sterile — associated with SLE | Vegetations on both surfaces of the valve |
| Carcinoid-associated | Increased serotonin and other secretory products from a carcinoid tumor | Plaque deposition on right-sided heart valves |
Acute vs. subacute isn't really about organism species so much as substrate: a highly virulent organism like S. aureus can invade a structurally normal valve outright, while the less-virulent viridans streptococci typically need a valve already roughened by prior damage to gain a foothold.
- Blood-culture-negative endocarditis can result from the fastidious HACEK group of organisms.
- Endocarditis caused by Streptococcus bovis should prompt evaluation for an underlying gastrointestinal malignancy.
- Prosthetic heart valves predispose to endocarditis caused by Staphylococcus epidermidis.
Rheumatic heart disease
- A delayed immune-mediated sequela of pharyngitis caused by group A streptococcus, driven by molecular mimicry between streptococcal and cardiac antigens.
- Acute rheumatic fever mainly affects children; can involve all layers of the heart (pancarditis), including pericarditis with effusion; myocarditis is the leading cause of early death in the acute phase.
- Endocarditis in rheumatic fever affects valves in a characteristic order — mitral, then aortic, then tricuspid, then pulmonary — with the mitral valve most often involved overall; repeated episodes cause chronic fibrotic, stenotic valve disease.
- Characteristic histology: the Aschoff body, a focus of fibrinoid necrosis with activated macrophages (Anitschkow cells) and giant cells.
- Extracardiac features: migratory polyarthritis, subcutaneous nodules, erythema marginatum, and Sydenham chorea.
- Diagnosis is supported by evidence of a recent group A streptococcal infection, most often an elevated antistreptolysin-O (ASO) titer.
09 Aneurysms & Aortic Dissection
Most abdominal aortic aneurysms arise on a background of chronic atherosclerotic vessel-wall injury, whose stepwise mechanism is covered in Atherosclerosis, Dyslipidemia & Lipid Pharmacology → Atherogenesis.
Aneurysm types
| Type | Typical cause | Characteristic location/finding |
|---|---|---|
| Arteriovenous fistula | Abnormal artery-to-vein communication, usually traumatic | Ischemic downstream changes; can cause high-output cardiac failure |
| Atherosclerotic | Chronic atherosclerosis, hypertension | Infrarenal abdominal aorta |
| Berry (saccular) | Congenital weakness at arterial branch points | Circle of Willis; risk of subarachnoid hemorrhage; associated with autosomal dominant polycystic kidney disease (gene on chromosome 16) |
| Dissecting | Hypertension, connective tissue disease (Marfan) | Sudden tearing pain; false lumen within the media |
| Syphilitic | Tertiary syphilis (obliterative endarteritis of the vasa vasorum) | Ascending aorta/aortic root; can cause aortic regurgitation |
| Mycotic | Bacteremic seeding of the arterial wall | Focal, often abdominal aorta |
True aneurysms (atherosclerotic, berry, syphilitic) involve the whole weakened wall bulging outward, whereas a dissection is a different process entirely — blood tracking within the media through an intimal tear, without the wall as a whole first dilating.
Abdominal aortic aneurysm (AAA)
- Focal dilation of the infrarenal aorta, most often atherosclerotic.
- Often asymptomatic until rupture; can present with vague abdominal pain and is easily mistaken for kidney stones in the emergency setting.
- Classic rupture triad = hypotension, abdominal/back pain, pulsatile abdominal mass.
- One-time ultrasound screening is recommended for men aged roughly 65–75 with any smoking history.
- Surgical repair is generally offered for a diameter ≥5.5 cm, growth ≥0.5 cm over 6 months, or any symptomatic aneurysm.
- Dissection is distinguished from myocardial infarction by pain that classically radiates to the back and by mediastinal widening rather than focal ECG changes.
Aortic dissection
- An intimal tear allows blood to dissect into the media, creating a false lumen.
- Hypertension is the dominant risk factor; connective tissue disorders (Marfan, Ehlers-Danlos) and prior trauma also predispose.
- Classified by whether the ascending aorta is involved: dissections involving the ascending aorta need urgent surgery; those confined to the descending aorta are usually managed medically unless complicated.
- Presentation: sudden, severe, tearing chest/back pain; widened mediastinum on chest x-ray.
- Initial management: rapid heart-rate and blood-pressure control (e.g., IV beta-blocker) before any further workup or intervention.
Traumatic aortic rupture & subclavian steal
- Traumatic aortic rupture: a sudden deceleration injury (motor vehicle collision, major fall) shears the aorta most often at the aortic isthmus, just distal to the left subclavian artery origin; chest x-ray classically shows a widened mediastinum.
- Subclavian steal syndrome: stenosis of the subclavian artery proximal to the vertebral artery origin causes blood to flow backward down the ipsilateral vertebral artery to supply the arm during exertion, "stealing" from the posterior cerebral circulation. Presents with arm ischemia/paresthesia plus vertebrobasilar symptoms (dizziness, vertigo) on exertion of the affected arm, and a systolic blood pressure difference >15 mm Hg between arms. Most often atherosclerotic, but can follow Takayasu arteritis or cardiac surgery.
Cholesterol embolization syndrome
- Cholesterol crystals dislodge from an atherosclerotic plaque (usually in the aorta) and shower into small distal arteries — classically after an invasive vascular procedure like angiography or angioplasty.
- Produces end-organ damage from small-vessel occlusion plus an inflammatory response: livedo reticularis, blue/discolored toes, acute kidney injury, stroke, or bowel ischemia.
- Because only small distal vessels are affected, proximal pulses typically remain palpable — a useful distinction from large-vessel thromboembolism.
Deep venous thrombosis
- A clot forms within a deep vein, producing unilateral limb swelling, redness, warmth, and pain.
- Predisposed by Virchow triad — Stasis (immobility, long travel, postoperative state), hypercoagulability (factor V Leiden and other clotting-cascade defects, oral contraceptives, pregnancy), and endothelial damage (exposed collagen activates the clotting cascade).
- Embolization risk is highest for proximal (femoral, iliac, popliteal) clots; isolated distal calf DVTs are less likely to embolize and often resolve on their own.
- A D-dimer test has good sensitivity to rule out DVT when pretest probability is low, but poor specificity; compression ultrasound with Doppler is the imaging test of choice.
- Heparin (unfractionated or low-molecular-weight) is used for prophylaxis and acute management; direct oral anticoagulants are used for ongoing treatment and prevention.
10 Vasculitides & Peripheral Vascular Disease
Takayasu arteritis can produce the same exertional arm-ischemia/vertebrobasilar picture described for atherosclerotic disease in Aneurysms & Aortic Dissection → Traumatic aortic rupture & subclavian steal.
By vessel size
Large vessel
- Takayasu arteritis: young Asian women; involves the aortic arch and origins of the great vessels ("aortic arch syndrome"); diminished carotid/radial/ulnar pulses ("pulseless disease") with low upper-extremity blood pressure, fever, night sweats, and a characteristic corkscrew-shaped, widened aorta on angiography.
- Temporal (giant cell) arteritis: older adults; headache, jaw claudication, visual loss, markedly elevated sedimentation rate; often with polymyalgia rheumatica; the most common vasculitis in adults.
Medium vessel
- Polyarteritis nodosa: necrotizing arteritis sparing the lungs; associated with hepatitis B; renal and GI involvement, fever, weight loss.
- Kawasaki disease: young children; fever, conjunctivitis, mucocutaneous changes, cervical lymphadenopathy; feared complication is coronary artery aneurysm.
- Buerger disease (thromboangiitis obliterans): classically young men of Jewish descent who smoke heavily; segmental, full-thickness vasculitis of small/medium arteries and veins of the extremities, which can extend to adjacent nerves, with Raynaud phenomenon and ulceration/gangrene.
Sorting vasculitides by vessel size caliber is a more reliable exam strategy than memorizing each disease in isolation — it predicts the pattern of organ involvement (large vessel = claudication/pulse deficits, small vessel = glomerulonephritis/purpura) even before recalling the specific antibody or demographic clue.
Small vessel
- Granulomatosis with polyangiitis (Wegener): c-ANCA positive; more common in males; classic triad of necrotizing vasculitis, necrotizing granulomas of the respiratory tract, and necrotizing glomerulitis; presents with cough, sinus/nasal septum ulceration, and red blood cell casts in the urine.
- Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): p-ANCA positive; asthma, eosinophilia, and vasculitis.
- IgA vasculitis (Henoch-Schönlein purpura): children, often atopic and following an upper respiratory infection; hemorrhagic urticaria, palpable purpura, arthralgia, abdominal pain, and IgA-mediated renal disease with red blood cell casts.
Not a true vasculitis but relevant
- Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu): autosomal dominant; fragile telangiectatic vessels causing recurrent epistaxis and GI bleeding; notably more common in Utah's Mormon population due to a founder effect.
- Kaposi sarcoma: HHV-8–driven vascular neoplasm, classically in the setting of advanced HIV/AIDS.
11 Conduction System & Cardiac Physiology
Heart position, pericardium & coronary blood supply
- The left atrium forms the most posterior part of the heart — an enlarged left atrium (e.g., mitral stenosis) can compress the esophagus (causing dysphagia) or the left recurrent laryngeal nerve (causing hoarseness, called Ortner syndrome).
- The right ventricle is the most anterior chamber and so is the structure most often injured in penetrating chest trauma; on the diaphragmatic (inferior) surface, the left ventricle makes up roughly two-thirds and the right ventricle roughly one-third.
- The pericardium has three layers, outer to inner: fibrous pericardium, parietal (serous) pericardium, and epicardium (visceral pericardium) — with the pericardial space in between. The pericardium is innervated by the phrenic nerve, which is why pericarditis can refer pain to the neck, shoulder, or arm.
- The left anterior descending (LAD) artery supplies the anterior two-thirds of the interventricular septum, the anterolateral papillary muscle, and the anterior LV wall — it is the vessel most often occluded in MI.
- The posterior descending artery (PDA) supplies the posterior third of the septum, the posterior two-thirds of the ventricular walls, the posteromedial papillary muscle, and (usually) the SA and AV nodes; an infarct here can cause nodal dysfunction such as bradycardia or heart block.
- Coronary "dominance" refers to which vessel gives rise to the PDA: right-dominant (PDA from the RCA) is most common, left-dominant (PDA from the LCX) occurs in roughly 5–10%, and codominant circulation (PDA from both) in roughly 10–20%.
- The right (acute) marginal artery supplies the right ventricle; the coronary sinus runs in the left atrioventricular groove and drains into the right atrium, and normally carries the most deoxygenated blood in the body.
- Coronary blood flow to the left ventricle and interventricular septum peaks in early diastole, when the myocardium is relaxed and not compressing its own vessels — unlike most other organs, which are perfused mainly during systole.
- The LAD artery is the vessel most often occluded in MI; the PDA supplies the SA and AV nodes, so inferior infarcts can cause bradyarrhythmias.
Electrical conduction pathway
- The SA node is the dominant pacemaker because it has the fastest intrinsic rate of spontaneous phase-4 depolarization.
- Nodal tissue (SA, AV) depolarizes via slow inward calcium current; working atrial/ventricular myocardium depolarizes via fast sodium current.
- The AV node deliberately conducts slowly, which (1) lets the atria finish contracting and empty into the ventricles before ventricular systole and (2) protects the ventricles from excessively fast atrial rates.
- Conduction velocity tracks the steepness (upstroke) of phase 0, not the total duration of the action potential.
- The SA node sits in the upper crista terminalis near the SVC; the AV node sits in the interatrial septum near the opening of the coronary sinus and is supplied by the PDA (hence the nodal dysfunction seen with inferior/PDA-territory infarcts).
- Intrinsic pacemaker rate, fastest to slowest: SA node > atria > AV node > bundle of His/Purkinje fibers/ventricles — this hierarchy is what allows a slower "escape" pacemaker to take over if a faster one fails.
- Conduction velocity, fastest to slowest: His-Purkinje system > atria > ventricles > AV node (mnemonic: "He Parks At Ventura Avenue").
Pacemaker vs. myocardial action potentials
| Phase | Ventricular myocyte | SA/AV nodal cell |
|---|---|---|
| 0 (upstroke) | Fast Na⁺ channels open — steep upstroke | Voltage-gated Ca²⁺ channels open — slower, less steep upstroke, giving the AV node its intrinsically slow conduction |
| 1 | Brief initial repolarization as Na⁺ channels inactivate | Absent |
| 2 (plateau) | Ca²⁺ influx balances K⁺ efflux, producing a plateau that drives excitation-contraction coupling | Absent |
| 3 | K⁺ efflux repolarizes the cell as Ca²⁺ channels close | K⁺ efflux repolarizes the cell as Ca²⁺ channels close |
| 4 | Stable resting potential | Slow spontaneous diastolic depolarization driven by the "funny current" (If) through HCN channels — this is what gives nodal tissue automaticity |
Nodal cells lack the plateau (phases 1–2) entirely because they never open fast Na⁺ channels in the first place — their whole action potential runs on the slower Ca²⁺ current, which is exactly why AV-nodal conduction is slow and why calcium channel blockers (not sodium channel blockers) are the drugs that act there.
- Acetylcholine and adenosine slow phase-4 depolarization (↓ heart rate); catecholamines speed it up (↑ heart rate) by increasing the likelihood that HCN channels are open.
- Because the fast Na⁺ channels in nodal cells are permanently inactivated at their less-negative resting potential, the AV node relies on the slower Ca²⁺-driven upstroke — the cellular basis for its role in intentionally delaying transmission from atria to ventricles.
Chronotropy, inotropy, and loading conditions
- Chronotropy = rate effect, driven by how fast the SA node depolarizes.
- Inotropy = contractility effect, driven largely by cytosolic calcium available to the contractile apparatus.
- Sympathetic β1 stimulation and cardiac glycosides both raise intracellular calcium and boost inotropy.
- Preload ≈ ventricular filling/stretch; more stretch → stronger contraction (Frank–Starling), up to a physiologic limit beyond which performance falls.
- Afterload for the left ventricle ≈ aortic pressure, set largely by total peripheral resistance; higher afterload forces the ventricle to work harder to eject the same volume.
Cardiac cycle — phase by phase
- Isovolumetric contraction: mitral valve closes → aortic valve opens; ventricular volume constant, pressure rising steeply; peak myocardial oxygen demand.
- Ejection: aortic valve open, blood leaves ventricle, volume falls.
- Isovolumetric relaxation: aortic valve closes → mitral valve opens; volume constant, pressure falling.
- Rapid filling: immediately after mitral valve opens.
- Reduced (diastasis) filling: passive filling slows just before atrial systole.
- Heart sounds: S1 = mitral/tricuspid closure (start of systole); S2 = aortic/pulmonic closure (start of diastole); S3 = rapid ventricular filling (normal in youth, pathologic in volume overload/heart failure); S4 = atrial contraction against a stiff ventricle.
- Jugular venous waveform: a wave = atrial contraction; c wave = tricuspid bulging into the atrium during isovolumetric ventricular contraction; v wave = atrial filling against a closed tricuspid valve.
- On the pressure–volume loop: increased contractility raises stroke volume/ejection fraction and lowers end-systolic volume; increased afterload lowers stroke volume and raises end-systolic volume; increased preload raises stroke volume (Frank–Starling).
Frank–Starling (contractility) curves
- Plotting stroke volume (or cardiac output) against ventricular end-diastolic volume (preload) gives the Frank–Starling curve: within physiologic limits, more stretch produces a stronger contraction.
- Positive inotropes (catecholamines, digoxin, exercise) shift the whole curve upward and to the left — more output for the same preload.
- Loss of functional myocardium (e.g., after MI), acute beta-blockade, non-dihydropyridine CCBs, and heart failure shift the curve downward and to the right — less output for the same preload.
- A failing heart placed back on a positive inotrope moves partway back up toward — but usually not fully onto — the normal curve.
Movement along a single Frank–Starling curve reflects a change in preload alone; a shift of the whole curve up or down reflects a change in contractility — conflating the two is the most common way to misread these curves on a test.
Splitting of S2
| Pattern | Mechanism |
|---|---|
| Physiologic splitting | Inspiration → ↑ venous return to the right heart → longer RV ejection time → pulmonic closure (P2) is delayed relative to aortic closure (A2); the split widens on inspiration and narrows on expiration |
| Wide splitting | An exaggeration of the normal pattern from delayed RV emptying (e.g., pulmonic stenosis, right bundle branch block) |
| Fixed splitting | The split no longer changes with respiration; classic for ASD, where a persistent left-to-right shunt keeps right-sided volume — and pulmonic closure delay — constant |
| Paradoxical splitting | Aortic closure is delayed (e.g., aortic stenosis, left bundle branch block), so the normal order reverses (P2 before A2); splitting is then heard on expiration and paradoxically disappears on inspiration |
All four patterns reduce to one question — which valve closes later, and does that delay change with respiration? Fixed splitting means the delay is constant (ASD equalizes volumes across the cycle); paradoxical splitting means the delayed valve is A2 instead of P2, so the whole respiratory pattern flips.
Neurohormonal regulation
- Baroreceptors in the carotid sinus and aortic arch sense stretch; carotid input travels via CN IX, aortic arch input via CN X, both relaying to the nucleus tractus solitarius in the medulla.
- Rising pressure → increased vagal (parasympathetic) tone → slower heart rate and lower pressure; falling pressure has the opposite effect, and this baroreceptor reflex is the body's key acute compensation for hypovolemic shock.
- Carotid sinus hypersensitivity — an exaggerated response to gentle pressure over the carotid sinus (tight collar, shaving, carotid massage) — can trigger enough reflex bradycardia and vasodilation to cause presyncope or syncope; risk rises with atherosclerosis, prior neck surgery, or older age.
- Peripheral chemoreceptors (carotid and aortic bodies) respond to a falling PO₂ (below roughly 60 mm Hg), a rising PCO₂, and a falling pH. Central chemoreceptors in the medulla respond only to CO₂/pH changes in brain interstitial fluid, not directly to oxygen, and become progressively less sensitive with chronic CO₂ retention (e.g., COPD) — shifting the drive to breathe onto the peripheral (hypoxic) chemoreceptors.
- The Cushing reflex is a triad of hypertension, bradycardia, and irregular respiration seen with rising intracranial pressure: cerebral ischemia raises sympathetic tone and blood pressure, and the resulting stretch then triggers a baroreceptor-mediated reflex bradycardia.
- Atrial natriuretic peptide is released by stretched atrial myocytes and counteracts the renin-angiotensin-aldosterone (RAA) axis: it promotes natriuresis, vasodilation, and inhibits renin.
- Antidiuretic hormone (vasopressin) increases free-water reabsorption in the collecting duct and constricts arterioles, raising both volume and resistance.
Local blood flow autoregulation
Most organs adjust their own vascular tone to keep blood flow roughly constant across a range of perfusion pressures, largely through locally produced vasodilator metabolites.
| Organ | What drives autoregulation |
|---|---|
| Heart | Local vasodilatory metabolites — nitric oxide, CO₂, falling O₂ |
| Brain | Local vasodilatory metabolites — mainly CO₂/pH |
| Skeletal muscle | During exercise, vasodilatory metabolites: CO₂, H⁺, adenosine, lactate, K⁺ (mnemonic "CHALK"); sympathetic tone dominates at rest |
| Kidney | Myogenic stretch response of the afferent arteriole plus tubuloglomerular feedback |
| Skin | Sympathetic vasoconstriction — the main lever for temperature regulation, not local metabolites |
| Lungs | The exception to the rule — local hypoxia causes vasoconstriction (not dilation), which usefully redirects blood flow away from poorly ventilated alveoli |
Pulmonary hypoxic vasoconstriction looks backwards next to every other organ's response, but it's actually the same underlying goal — matching perfusion to where it's useful — applied to a system where "useful" means diverting blood away from unventilated alveoli rather than toward under-oxygenated tissue.
Capillary fluid exchange
- Fluid movement across the capillary wall is governed by the balance of four Starling forces: capillary hydrostatic pressure (pushes fluid out), interstitial hydrostatic pressure (pushes fluid in), plasma oncotic pressure (pulls fluid in), and interstitial oncotic pressure (pulls fluid out).
- Edema results when this balance shifts toward net outward flow: raised capillary hydrostatic pressure (e.g., heart failure), raised capillary permeability (toxins, infection, burns), raised interstitial oncotic pressure (lymphatic blockage), or reduced plasma oncotic pressure (nephrotic syndrome, liver failure, malnutrition).
Key equations
| Relationship | Meaning |
|---|---|
| CO = SV × HR | Cardiac output from stroke volume and heart rate |
| MAP ≈ CO × TPR | Mean pressure driven by output and resistance |
| Resistance ∝ 1 / r⁴ | Small changes in vessel radius produce large resistance changes |
| SV = EDV − ESV | Stroke volume as the difference between end-diastolic and end-systolic volume |
| EF = SV / EDV | Ejection fraction — the main index of contractility; normal is roughly 50–70%. Falls in systolic heart failure, usually stays normal in isolated diastolic heart failure |
| PP = SBP − DBP | Pulse pressure — directly proportional to stroke volume, inversely proportional to arterial compliance |
| Fick: CO = VO₂ / (arterial−venous O₂ content) | Alternate way to calculate cardiac output |
| Wall tension ∝ pressure × radius (Laplace's law) | Explains why ventricular dilation and rising pressure both raise myocardial oxygen demand, and why hypertrophy (increasing wall thickness) helps normalize wall stress |
- Resistances in series add directly; resistances in parallel combine reciprocally, so recruiting parallel capillary beds lowers overall resistance.
- Myocardial oxygen demand rises with contractility, afterload, heart rate, and ventricular wall tension; the coronary sinus normally carries the most deoxygenated blood in the body, reflecting how much oxygen the heart itself extracts.
- Pulmonary capillary wedge pressure (PCWP), measured via a Swan-Ganz catheter, approximates left atrial pressure and left ventricular end-diastolic pressure — except in mitral stenosis, where the stenotic valve makes PCWP read higher than the true LVEDP.
- Pulse pressure widens in aortic regurgitation, age-related aortic stiffening (isolated systolic hypertension), obstructive sleep apnea, and high-output states (anemia, hyperthyroidism, transient with exercise); it narrows in aortic stenosis, cardiogenic shock, cardiac tamponade, and advanced heart failure.
12 Cardiac Embryology
Origin & early folding
- Heart tissue arises from splanchnic mesoderm.
- Two endocardial tubes form cranially and fuse into a single tube as the embryo folds.
- Folding brings the tube into the thorax, ventral to the foregut.
Five dilations of the primitive heart tube
| Embryonic segment | Adult derivative |
|---|---|
| Truncus arteriosus | Root of aorta + root of pulmonary trunk |
| Bulbus cordis | Outflow (conus) portions of both ventricles |
| Primitive ventricle | Trabeculated body of both ventricles |
| Primitive atrium | Trabeculated body of both atria |
| Sinus venosus | Smooth part of right atrium, coronary sinus, oblique vein of left atrium |
This table is the map most congenital defects hang off of — a septation failure at the truncus/bulbus level gives the outflow-tract defects (transposition, truncus arteriosus, tetralogy), while abnormalities lower down affect the atria and ventricles instead, so knowing which segment gives rise to which structure lets you predict the defect from the anatomy rather than memorizing each syndrome separately.
Septation
- Two overlapping atrial septa (septum primum, septum secundum) build the interatrial wall.
- Their offset openings create the foramen ovale, a right-to-left shunt in fetal life.
- Fetal pulmonary vascular resistance is high, so right atrial pressure exceeds left — blood crosses the shunt rather than entering collapsed fetal lungs.
- At birth, lung expansion drops pulmonary resistance, left atrial pressure rises above right, and the septa are pressed together, functionally sealing the shunt.
- Interventricular septum forms from muscular ingrowth below plus membranous contributions from the spiral (aorticopulmonary) septum, the right and left bulbar ridges, and the endocardial (AV) cushions above.
- Abnormal development of the aorticopulmonary/spiral septum underlies tetralogy of Fallot, transposition of the great vessels, and persistent truncus arteriosus.
- Dextrocardia (heart positioned rightward in the thorax) may occur alone with associated anomalies, or as part of full situs inversus, which is often otherwise clinically silent unless paired with ciliary dysfunction, as in primary ciliary dyskinesia (Kartagener syndrome — immotile cilia from a dynein arm defect, causing chronic lung disease and male infertility).
Valve development
- The aortic and pulmonary (semilunar) valves form from endocardial cushions within the outflow tract.
- The mitral and tricuspid (AV) valves form from the fused endocardial cushions of the AV canal.
- Valve anomalies from this process range from stenotic or regurgitant leaflets to a frankly absent (atretic) valve or an abnormally displaced one.
Aortic arch derivatives
- Six paired pharyngeal arch arteries form sequentially; not all persist.
- Arch 1 & 2 → mostly regress (contribute to the maxillary artery and stapedial artery, respectively).
- Arch 3 → common carotid arteries.
- Arch 4 → left: aortic arch; right: proximal subclavian artery.
- Arch 5 → regresses without an adult derivative.
- Arch 6 → proximal pulmonary arteries + ductus arteriosus.
- The paired dorsal aortae run the length of the embryo and fuse in the midline to form the descending aorta.
Venous system
- Vitelline veins → ductus venosus, hepatic sinusoids, portal vein, superior and inferior mesenteric veins, and part of the IVC.
- Umbilical veins: only the left persists prenatally, carrying oxygenated placental blood to the fetus via the ductus venosus; it becomes the ligamentum teres hepatis after birth. The right umbilical vein regresses entirely.
- Cardinal veins: anterior → superior vena cava/internal jugular system; posterior → inferior vena cava, azygos system, renal and common iliac veins.
Fetal circulation shunts
| Shunt | Route | Postnatal fate |
|---|---|---|
| Ductus venosus | Bypasses hepatic sinusoids | Ligamentum venosum |
| Foramen ovale | Right atrium → left atrium | Fossa ovalis (functional closure at birth, anatomic closure later) |
| Ductus arteriosus | Pulmonary trunk → descending aorta | Ligamentum arteriosum |
All three shunts exist to bypass structures that don't do useful work before birth (the collapsed lungs, the not-yet-functioning liver circulation) — and all three close because the same event, the first breath, simultaneously drops pulmonary resistance and reverses the atrial pressure gradient that kept them open.
- Ductus arteriosus patency is maintained by locally produced prostaglandin E2 and low fetal oxygen tension.
- After birth, rising oxygen tension and falling prostaglandin levels drive functional closure within the first days of life.
- Clinically: indomethacin (a prostaglandin-synthesis inhibitor) helps close a patent ductus; exogenous prostaglandin E1 keeps it open when systemic or pulmonary flow depends on the shunt.
- Umbilical arteries carry deoxygenated fetal blood to the placenta — one of the few arterial systems in the body that does not carry oxygenated blood, along with the pulmonary arteries.
Congenital heart defects — quick reference
| Defect | Core lesion | Typical presentation |
|---|---|---|
| Atrial septal defect | Ostium secundum most common (75–80% of cases), followed by ostium primum (low septum) and sinus venosus (high septum) subtypes | Often silent for decades; fixed split S2; left-to-right shunt; roughly 3× more common in women. A patent foramen ovale is technically the most common form of ASD. |
| Ventricular septal defect | Membranous type most common (~90%); the single most common congenital heart defect overall (~33%) | Holosystolic murmur; a louder murmur implies a smaller defect (higher-velocity jet); large defects can present as heart failure at birth, while small defects often close spontaneously; more common in males |
| Patent ductus arteriosus | Failure of postnatal closure; often related to prematurity/hypoxemia or structural defects | Continuous, machine-like murmur; the second most common congenital heart defect |
| Coarctation of aorta | Infantile: proximal to the ductus; adult: juxtaductal, distal to the left subclavian artery origin | Infantile form: lower-limb cyanosis and right heart failure at birth. Adult form: upper-extremity hypertension, weak femoral pulses, rib notching from collateral flow. More common in males, and in females with Turner syndrome |
| Tetralogy of Fallot | Anterior malalignment of the infundibular septum → overriding aorta, VSD, pulmonary stenosis, and right ventricular hypertrophy | Right-to-left shunt, cyanosis (may not be present at birth), boot-shaped heart, squatting relieves symptoms; survival to adulthood is possible |
| Transposition of great vessels | Aorta arises from the RV, pulmonary artery from the LV, creating separate parallel circuits | Incompatible with life without a shunt; cyanosis present at birth; associated with maternal diabetes |
- Shunt lesions whose names contain the letter "D" (ASD, VSD, PDA, AVSD) start out left-to-right and acyanotic; chronic left-to-right shunting can reverse into a cyanotic right-to-left shunt (Eisenmenger physiology) once pulmonary vascular resistance rises.
- Right-to-left shunts (tetralogy of Fallot, transposition) are cyanotic from the outset and predispose to clubbing, hypertrophic osteoarthropathy, and secondary polycythemia from chronic hypoxemia.
- An atrioventricular septal defect (endocardial cushion defect) is strongly associated with Down syndrome.
- A paradoxical embolus originates in the venous circulation and crosses a patent foramen ovale or ASD to enter the arterial circulation and cause a systemic (e.g., cerebral) embolic event.
Other cyanotic (right-to-left) lesions
| Defect | Core lesion | Typical presentation |
|---|---|---|
| Persistent truncus arteriosus | Spiral (aorticopulmonary) septum never forms, so a single great vessel serves both circuits — usually with an accompanying VSD | Early, severe cyanosis and heart failure; requires early surgical correction |
| Tricuspid atresia | Tricuspid valve fails to form and the right ventricle is underdeveloped; survival depends on an ASD plus a VSD or PDA to mix blood | Cyanosis from birth; ECG shows right atrial and left ventricular hypertrophy |
| Total anomalous pulmonary venous return | Pulmonary veins drain into the systemic venous circulation instead of the left atrium | Requires a coexisting shunt (ASD, sometimes PDA) to sustain cardiac output; cyanosis |
| Ebstein anomaly | Tricuspid leaflets are displaced downward into the right ventricle, "atrializing" part of it | Tricuspid regurgitation, accessory conduction pathways, right heart failure; linked to lithium exposure in utero |
A simple way to remember the classic right-to-left ("blue baby") lesions is by vessel count in the name — truncus arteriosus (1 vessel), transposition (2 switched vessels), tricuspid atresia (3 = "tri"), tetralogy of Fallot (4 = "tetra"), and total anomalous pulmonary venous return (5 letters).
Congenital defect associations
| Exposure / syndrome | Associated defect(s) |
|---|---|
| Prenatal alcohol exposure | VSD, PDA, ASD, tetralogy of Fallot |
| Congenital rubella | PDA, pulmonary artery stenosis, septal defects |
| Down syndrome | AV septal (endocardial cushion) defect, VSD, ASD |
| Maternal diabetes | Transposition of the great vessels, truncus arteriosus, tricuspid atresia, VSD |
| Marfan syndrome | Mitral valve prolapse, thoracic aortic aneurysm/dissection, aortic regurgitation |
| Prenatal lithium exposure | Ebstein anomaly |
| Turner syndrome | Bicuspid aortic valve, aortic coarctation/dissection |
| Williams syndrome | Supravalvular aortic stenosis |
| 22q11 deletion syndromes | Truncus arteriosus, tetralogy of Fallot |
- Persistent pulmonary hypertension of the newborn is a related but distinct entity: pulmonary vascular resistance stays abnormally high after birth (often from meconium aspiration or neonatal pneumonia), keeping the foramen ovale and ductus arteriosus shunting right-to-left and producing a cyanotic, tachypneic newborn with equal pulses.
13 Cardiac Tumors & Pericardial Disease
Cardiac tumors
- Metastatic tumors to the heart are far more common than primary cardiac tumors.
- Myxoma: the most common primary cardiac tumor in adults, usually arising in the left atrium; can cause a "ball-valve" obstruction of the mitral orifice, syncope, and constitutional symptoms.
- Rhabdomyoma: the most common primary cardiac tumor in children; associated with tuberous sclerosis; histologically shows characteristic "spider cells" with glycogen-rich vacuoles.
Pericarditis
- Most often idiopathic or viral (coxsackievirus A or B, producing serous pericarditis); also tuberculosis (hemorrhagic pericarditis), uremia (serofibrinous), SLE and scleroderma (serous), and post-MI (Dressler syndrome, fibrinous).
- Sharp, pleuritic chest pain that worsens lying flat/with inspiration and improves sitting forward; pericardial friction rub; jugular venous distension that rises further with inspiration (Kussmaul sign); distant heart sounds; diffuse ST elevation on ECG.
- Unlike an MI, the ST elevation of pericarditis is diffuse across leads rather than confined to the distribution of one coronary territory, and is not accompanied by the reciprocal QRS changes seen in infarction.
- Chronic/recurrent pericarditis can progress to constrictive pericarditis, which mimics right-sided heart failure due to a rigid, non-compliant, calcified pericardium obliterating the pericardial cavity.
Jugular venous waveform abnormalities
| Condition | Waveform change | Why |
|---|---|---|
| Atrial fibrillation | Absent a wave | No coordinated atrial contraction to generate it |
| Tricuspid regurgitation | Absent (or blunted) x descent | The regurgitant jet keeps right atrial pressure elevated through what should be the relaxation dip |
| Constrictive pericarditis | Prominent y descent | The rigid pericardium lets the atrium empty into the ventricle rapidly at first, then abruptly halts filling |
| Cardiac tamponade | Absent (or blunted) y descent | Fluid compressing the heart prevents the rapid early-diastolic filling that produces the descent |
Tamponade and constrictive pericarditis can look similar clinically (both raise JVP, both show Kussmaul-like features), but the y descent points opposite directions — tamponade prevents early diastolic filling altogether, while a rigid but non-compressive pericardium in constriction still allows a rapid early rush before abruptly halting it.
Cardiac tamponade
- Fluid accumulation in the pericardial space compresses the heart, limiting ventricular filling; the most common causes are neoplasm, idiopathic pericarditis, and uremia.
- Classic findings: elevated intracardiac/intrapericardial pressure, reduced cardiac output, muffled heart sounds, and jugular venous distension (Beck triad along with hypotension).
- Pulsus paradoxus: an exaggerated (>10 mm Hg) inspiratory drop in systolic blood pressure. Mechanistically, inspiration increases venous return to the right ventricle, but with a non-compliant pericardium the interventricular septum bows into the left ventricle instead, reducing left ventricular filling and stroke volume. Beyond tamponade, this same pattern is seen in constrictive pericarditis and obstructive airway disease (croup, obstructive sleep apnea, asthma/COPD) — remembered as "COAT."
- Echocardiography shows a pericardial effusion along with systolic collapse of the right atrium, diastolic collapse of the right ventricle, and a plethoric, non-collapsing IVC; the ECG may show low voltage and electrical alternans from the heart swinging within the effusion.
- Treatment is pericardiocentesis to relieve the compression; the needle traverses skin, superficial fascia, pectoralis major, the intercostal muscle layers, and the fibrous and parietal serous pericardium.
14 Shock
Cardiac tamponade is one specific cause of obstructive shock in the table below; its compressive mechanism and exam findings are explained in Cardiac Tumors & Pericardial Disease → Cardiac tamponade.
- Shock = a state in which oxygen delivery fails to meet tissue metabolic demand.
- Common signs: tachycardia, hypotension, oliguria, altered mental status, weak pulses.
| Type | Systemic resistance | Cardiac output | Mechanism | Examples |
|---|---|---|---|---|
| Cardiogenic | ↑ | ↓ | Pump failure | Massive MI, arrhythmia, heart failure |
| Hypovolemic | ↑ | ↓ | Volume loss | Hemorrhage, severe dehydration, burns |
| Obstructive — extracardiac compression | ↑ | ↓ | Mechanical obstruction of venous return before it reaches the heart | Tension pneumothorax, massive hemothorax (low/normal filling pressure) |
| Obstructive — cardiac tamponade | ↑ | ↓ | Mechanical obstruction of ventricular filling itself | Cardiac tamponade (high/very high filling pressure) |
| Septic / distributive | ↓ | ↑ (early) / variable | Pathologic vasodilation, increased venous capacitance | Gram-negative sepsis, direct endotoxin injury |
| Neurogenic | ↓ | ↓ | Loss of sympathetic vascular tone | Severe cerebral, brainstem, or spinal cord injury |
| Anaphylactic | ↓ | ↑ | Histamine-driven vasodilation and increased venous capacitance | Type I hypersensitivity reaction to an allergen |
The resistance column is the fastest way to sort these on an exam: high-resistance shock states (cardiogenic, hypovolemic, obstructive) are all "pump or volume" problems triggering compensatory vasoconstriction, while low-resistance states (septic, anaphylactic, neurogenic) are primary vasodilation problems the body can't compensate for — septic shock's early high-output phase is the trap, since it can transiently look hyperdynamic before decompensating.
- Coronary (and renal, cerebral) blood flow is normally autoregulated to match local tissue metabolic demand, mediated in part by nitric oxide and adenosine.
- Sustained shock produces characteristic end-organ injury: acute tubular necrosis in the kidney, neuronal necrosis in the brain, fatty change in the heart and liver, patchy hemorrhage in the colon, and pulmonary edema from acute lung injury.
- Septic and neurogenic shock present with warm extremities due to vasodilation, in contrast to the cool, clammy extremities of cardiogenic and hypovolemic shock.
15 Drugs With Cardiovascular Toxicity
QT-prolonging drugs share a final common pathway to torsades de pointes, whose ECG appearance and management are covered in Arrhythmias & Antiarrhythmic Pharmacology → Tachyarrhythmia patterns.
- Thrombotic risk: estrogen-containing oral contraceptives increase venous thromboembolic risk.
- Direct cardiotoxicity: anthracyclines (doxorubicin, daunorubicin) cause dose-dependent, largely irreversible cardiomyopathy; tricyclic antidepressants and lithium can also impair cardiac conduction/function.
- QT prolongation / torsades risk: class IA and class III antiarrhythmics, and tricyclic antidepressants.